Bill Emker, Lei Wang, Helena Fan, and Dean Grimm, The Lotus Group Dear Future Biostatistician, If you are finishing your PhD and trying to enter pharma or biotech right now, you have felt how difficult this market has become. From 2020 through 2022, biotech grew fast. Capital flowed, companies hired aggressively, and entry-level positions were abundant. Then funding … [Read more...] about Cracking the Industry Code: A Letter to Future Biostatisticians Entering the Pharmaceutical Industry

